Comparison of Efficacy & Tolerability Between Ganfort vs Krytantek in Mexican Patients With Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Study Identifier
ALLE-GANFORT-001-4-2011
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Glaucoma - Open Angle
  • Study Drug
  • Ganforti
  • Krytantek
  • Phase
    N/A
    Sex
    Female & Male
    Age
    N/A

    Protocol Summary

    The objective of this phase IV clinical multi-center trial will be to compare the efficacy and safety of Ganforti® versus Krytantek®, using a cross-over design during a six month period (including a one-month wash-in period) in POAG and OH patients.

    Study Locations

    Location
    Status
    Location
    Global Galucoma Institute
    Guadalajara, Jalisco, Mexico
    Status
    Not applicable
    Location
    Asociación Para Evitar La Ceguera en México
    Mexico City, Mexico City, Mexico
    Status
    Not applicable
    Location
    Hospital de Nuestra Señora de la Luz
    Mexico City, Mexico City, Mexico
    Status
    Not applicable
    Location
    Instituto Oftalmológico Conde de Valencian
    Mexico City, Mexico City, Mexico
    Status
    Not applicable